We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Despite Adequate Response, HeartSine Gets FDA Warning
Despite Adequate Response, HeartSine Gets FDA Warning
May 21, 2010
HeartSine Technologies received a warning letter citing documentation issues with medical device tracking and reporting for its automatic external defibrillators — even though the FDA acknowledges that the company’s response to the Form 483 citations was adequate.